Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Integra LifeSciences
IART
$1.34B
| $3.77M | ﹤0.01% |
55,258
+16,666
| +43% | +$1.18M |
|
|
SFIX
1752
PUT
Stitch Fix
SFIX
$560M
| $3.77M | ﹤0.01% |
62,500
-18,800
| -23% | -$963K |
|
1753
QuidelOrtho
QDEL
$838M
| $3.77M | ﹤0.01% |
29,394
-5,227
| -15% | -$615K |
|
|
HTLF
1754
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.76M | ﹤0.01% |
79,922
+5,242
| +7% | +$261K |
|
1755
CVB Financial
CVBF
$3.99B
| $3.75M | ﹤0.01% |
182,464
-38,158
| -17% | -$833K |
|
1756
StoneCo
STNE
$2.58B
| $3.75M | ﹤0.01% |
55,970
-134,273
| -71% | -$8.7M |
|
1757
Saic
SAIC
$5.35B
| $3.74M | ﹤0.01% |
42,653
-21,298
| -33% | -$1.9M |
|
|
CNST
1758
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $3.74M | ﹤0.01% |
110,787
+44,516
| +67% | +$1.13M |
|
1759
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $3.73M | ﹤0.01% |
63,938
+26,688
| +72% | +$1.55M |
|
1760
Allegiant Air
ALGT
$2.57B
| $3.73M | ﹤0.01% |
19,212
+1,566
| +9% | +$351K |
|
1761
Philips
PHG
$26.1B
| $3.73M | ﹤0.01% |
90,782
+89,090
| +5,265% | +$4.12M |
|
1762
CALL
Guardant Health
GH
$22.6B
| $3.73M | ﹤0.01% |
30,000
| – | – |
|
1763
Globus Medical
GMED
$11.2B
| $3.72M | ﹤0.01% |
48,046
+34,464
| +254% | +$2.45M |
|
1764
PUT
Booking.com
BKNG
$161B
| $3.72M | ﹤0.01% |
42,500
| – | – |
|
1765
CubeSmart
CUBE
$9.41B
| $3.71M | ﹤0.01% |
80,125
-10,331
| -11% | -$446K |
|
1766
Fate Therapeutics
FATE
$326M
| $3.69M | ﹤0.01% |
42,544
-67,235
| -61% | -$5.42M |
|
1767
State Street SPDR S&P Dividend ETF
SDY
$23.9B
| $3.69M | ﹤0.01% |
30,190
-189
| -0.6% | -$23.4K |
|
1768
FTI Consulting
FCN
$4.18B
| $3.69M | ﹤0.01% |
27,016
+23,585
| +687% | +$3.32M |
|
1769
Choice Hotels
CHH
$4.8B
| $3.68M | ﹤0.01% |
30,988
+1,811
| +6% | +$211K |
|
1770
CALL
Okta
OKTA
$25.8B
| $3.67M | ﹤0.01% |
+15,000
| New | +$3.62M |
|
|
BBBY
1771
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.67M | ﹤0.01% |
110,161
-163,146
| -60% | -$4.54M |
|
1772
Steven Madden
SHOO
$3.55B
| $3.66M | ﹤0.01% |
83,656
-21,398
| -20% | -$883K |
|
1773
BWX Technologies
BWXT
$15.6B
| $3.66M | ﹤0.01% |
62,981
+15,149
| +32% | +$974K |
|
1774
New Jersey Resources
NJR
$5.58B
| $3.66M | ﹤0.01% |
92,513
+6,791
| +8% | +$287K |
|
|
CS
1775
DELISTED
Credit Suisse Group
CS
| $3.65M | ﹤0.01% |
348,282
-148,112
| -30% | -$1.57M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.